By Sami Ramsammy and Matthew X. Lowe The Multiple Identities of Psychedelics Classic psychedelics, often referred to as hallucinogens, consist of
By Matthew X. Lowe, Research Director Originally published by Psychedelic Spotlight A new study looks at how an ayahuasca ceremony may help rebuild
By Matthew X Lowe, Ph.D. In recent years, the use of ayahuasca for both therapeutic and spiritual purposes has become more commonplace in
By Trey Brasher Beta-blockers are a class of drugs most commonly prescribed for reducing hypertension (lowering blood pressure) and widely considered one of the
People of varied religious backgrounds have associated psychedelics with enlightenment and spiritual practices for thousands of years. Records from 3780 to 3660 BCE mention
Last month, we had the honor of welcoming Dr. Gunther Weil, the only remaining member of the Harvard Psilocybin Project, to speak to our
By Trey Brasher & David Rosen, Ph.D. | 22 minute read Few discoveries in history have changed psychology more than the 1943
Psychedelics continue to prove their therapeutic value, making them beneficial tools for healing and transformational work. Most likely, if you’re reading this you share this
By Trey Brasher | 14 minute read On April 19th, 1943 in Basil, Switzerland, chemist Albert Hofmann took the world’s first trip on LSD. The
by Matthew X. Lowe, Ph.D., Director of Research for Unlimited Sciences Unlimited Sciences is a non-profit organization focused on driving psychedelics research forward, and
©2023 Unlimited Sciences. All rights reserved.
Our newsletter is meant to provide you with the latest news in psychedelic research, inform you about our work, and inspire you with compelling stories from all over the world about the power of psychedelics.